We are international

We are here to help you. We invite you to learn more about our full- and part-time staff members.

Susie Novis Durie

The IMF was founded in October of 1990 by Susie Novis, her late husband, Brian Novis, and Prof. Brian G.M. Durie as a means to advance myeloma research, and to develop and implement patient and physician educational programs in the area of multiple myeloma.

Susie was elected Executive Director of the IMF in 1992 and today holds the title of President of the Foundation. Under her direction the IMF has continued to experience impressive growth. Programs that she developed have become models for other organizations around the world. Susie's deep personal commitment to the myeloma community continues to drive the IMF forward -- towards a cure for myeloma.


Jennifer Scarne
Chief Financial Officer

Jennifer Scarne manages the daily financial operations of IMF. She is a Certified Public Accountant with twenty years of accounting and finance experience. Jennifer previously served as the Controller of Morgan Creek Productions. Prior to joining Morgan Creek, Jennifer was a Manager in Ernst and Young’s internal audit entertainment practice, representing such entertainment clients as The Walt Disney Company, AOL Time Warner and USA Networks. Jennifer volunteers her time serving on the Board of The Good Shepherd Center for Homeless Women and Children.


Diane Moran
Senior Vice President
Strategic Planning

Diane Moran, RN, MA, EdM is an experienced nurse with advanced degrees in education and organizational management, and a highly accomplished healthcare executive with more than two decades in the pharmaceutical industry prior to joining the IMF in April 2006.

Diane is the Senior Vice President of Strategic Planning for the IMF and reports directly to the president and Chairman of the Board.


Lisa Paik
Senior Vice President
Clinical Education & Research Initiatives

Lisa Paik joined the IMF in June 2001 as Director of Meeting Services, bringing with her extensive public relations and special events planning experience. Previously, Lisa was an Account Executive with Ogilvy Public Relations in Washington, DC. At Ogilvy, she specialized in consumer education programs and disease-awareness campaigns. At the IMF, Lisa currently oversees the IMF's research grant awards process, as well as all of the Foundation's CME & CE programs. She is the point person for the Health Medical companies accrediting clinical meetings and coordinates workshops for the International Myeloma Working Group (IMWG), a collaborative group of leading myeloma specialists that is charting the course to a cure, mentoring the next generation of innovative investigators, and improving lives through better care.


Daniel Navid
Senior Vice President Global Affairs
Mr. Navid is an American lawyer who has been based in Europe for 35 years. He has extensive experience in the fields of international law, diplomacy, capacity building, and management in the environment, development, and health fields. Mr. Navid’s most recent client has been the Fragility Fracture Network, a scientific society dedicated to supporting osteoporosis patients, which he helped establish as an international organization in Switzerland and for which he served as Chief Executive Officer from 2001 to 2009. Prior to that, he served for several years as a diplomat in the United Nations, served as the First Secretary General to the Convention on Wetlands of International Importance, and worked as a legal officer and Executive Officer at the International Union for Conservation of Nature and Natural Resources.

Pierre Sayad
Senior Vice President, Global Medical Affairs and Strategic Partnerships

Pierre Sayad completed his graduate work in Molecular Physiology from Loma Linda University, School of Medicine. In 2003, he began his pharmaceutical career at Eli Lilly and Company; and during his ten-year tenure there, Pierre helped launch four blockbuster neuroscience medicines for various mental illnesses. After Lilly, Pierre joined the management-consulting firm, Campbell Alliance. As a senior consultant, Pierre worked with executive clients at over 25 different pharmaceutical and biotech companies. In 2012, Onyx Pharmaceuticals recruited Pierre as head of Global Strategy and Operations for the Medical and Scientific Affairs Organization. He ultimately formalized and launched Onyx’s Global Strategic Partnerships program, and was heavily involved in Onyx’s transition to Amgen. As result of that role, Pierre has been very familiar with the IMF’s Black Swan Research Initiative and the organization’s other innovative platforms aimed at curing myeloma. Excited to help propel these important endeavors, Pierre joined the IMF in 2016.  He currently works directly with the President and the Chairman of the Board, and is committed to advancing myeloma treatment paradigms.